Patents by Inventor Thorbjorn Bjerke

Thorbjorn Bjerke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of alpha-MSH and EPO for preventing or treating ischemic conditions
    Publication number: 20060063705
    Abstract: Alpha-melanocyte stimulating hormone (?-MSH) or an equivalent is used, in conjunction with erythropoietin (EPO) or equivalent, to prevent or treat ischemic conditions.
    Type: Application
    Filed: November 1, 2005
    Publication date: March 23, 2006
    Inventors: Soren Nielsen, Jorgen Frokiaer, Thomas Jonassen, Thorbjorn Bjerke
  • Methods for treatment of diseases associated with inflammation under non-ischemic conditions
    Publication number: 20020061849
    Abstract: A disease associated with inflammation under non-ischemic conditions is treated or prevented by administering (1) &agr;-melanocyte simulating hormone (&agr;-MSH) and/or a &agr;-MSH equivalent, and/or (2) erythropoietin (EPO) and/or an EPO equivalent, to the individual in need thereof.
    Type: Application
    Filed: May 2, 2001
    Publication date: May 23, 2002
    Inventors: Soren Nielsen, Jorgen Frokiaer, Thomas Engelbrecht Norkild Jonassen, Thorbjorn Bjerke
  • Use of alpha-MSH and EPO for preventing or treating ischemic conditions
    Publication number: 20020037832
    Abstract: Alpha—melanocyte stimulating hormone (&agr;-MSH) or an equivalent is used, in conjunction with erythropoietin (EPO) or equivalent, to prevent or treat ischemic conditions.
    Type: Application
    Filed: May 2, 2001
    Publication date: March 28, 2002
    Inventors: Soren Nielsen, Jorgen Frokiaer, Thomas Engelbrecht Norkild Jonassen, Thorbjorn Bjerke